9ème congrès scientifique de l’IAS sur le VIH

Le 9ème congrès scientifique de l’IAS sur le VIH (IAS 2017), organisé par la Société internationale du SIDA (International AIDS Society), se déroulera à Paris, en France, du 23 au 26 juillet 2017.

NAM est ravi d’être le reporter officiel des nouvelles scientifiques en ligne pour ce congrès.

Nous couvrirons les recherches essentielles présentées pendant le congrès, et nous publierons les nouvelles en ligne sur www.aidsmap.com/ias2017


Inscrivez-vous pour nos bulletins électroniques gratuits

NAM's news coverage of the International AIDS Society's Conference on HIV Science has been made possible thanks to support from Gilead Sciences Europe Ltd. and Merck & Co. NAM's wider conference news reporting services have been supported by Janssen and ViiV Healthcare.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.